Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis.
Smith BN., Topp SD., Fallini C., Shibata H., Chen H-J., Troakes C., King A., Ticozzi N., Kenna KP., Soragia-Gkazi A., Miller JW., Sato A., Dias DM., Jeon M., Vance C., Wong CH., de Majo M., Kattuah W., Mitchell JC., Scotter EL., Parkin NW., Sapp PC., Nolan M., Nestor PJ., Simpson M., Weale M., Lek M., Baas F., Vianney de Jong JM., Ten Asbroek ALMA., Redondo AG., Esteban-Pérez J., Tiloca C., Verde F., Duga S., Leigh N., Pall H., Morrison KE., Al-Chalabi A., Shaw PJ., Kirby J., Turner MR., Talbot K., Hardiman O., Glass JD., De Belleroche J., Maki M., Moss SE., Miller C., Gellera C., Ratti A., Al-Sarraj S., Brown RH., Silani V., Landers JE., Shaw CE.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder. We screened 751 familial ALS patient whole-exome sequences and identified six mutations including p.D40G in theANXA11gene in 13 individuals. The p.D40G mutation was absent from 70,000 control whole-exome sequences. This mutation segregated with disease in two kindreds and was present in another two unrelated cases (P= 0.0102), and all mutation carriers shared a common founder haplotype. Annexin A11-positive protein aggregates were abundant in spinal cord motor neurons and hippocampal neuronal axons in an ALS patient carrying the p.D40G mutation. Transfected human embryonic kidney cells expressingANXA11with the p.D40G mutation and other N-terminal mutations showed altered binding to calcyclin, and the p.R235Q mutant protein formed insoluble aggregates. We conclude that mutations inANXA11are associated with ALS and implicate defective intracellular protein trafficking in disease pathogenesis.